Quark Pharmaceuticals Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 70

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 14

  • Investments
  • 1

Quark Pharmaceuticals General Information

Description

Developer of therapeutic Ribonucleic acid interference (RNAi) drugs based in Newark, California. The company offers services catering to the discovery and development of novel small interfering RNA (siRNA) therapeutics for renal protection in cardio-renal disease and neuroprotection in ophthalmology.

Contact Information

Formerly Known As
Quark Biotech, Quark Biotech Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 7999 Gateway Boulevard
  • Suite 310
  • Newark, CA 94560
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 7999 Gateway Boulevard
  • Suite 310
  • Newark, CA 94560
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quark Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quark Pharmaceuticals‘s full profile, request access.

Request a free trial

Quark Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic Ribonucleic acid interference (RNAi) drugs based in Newark, California. The company offers serv
Drug Discovery
Newark, CA
70 As of 2006

South San Francisco, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quark Pharmaceuticals Competitors (63)

One of Quark Pharmaceuticals’s 63 competitors is X-37, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
X-37 Venture Capital-Backed South San Francisco, CA
Biosplice Therapeutics Private Equity-Backed San Diego, CA
Voyager Therapeutics Formerly VC-backed Lexington, MA
Numerion Labs Venture Capital-Backed San Francisco, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
You’re viewing 5 of 63 competitors. Get the full list »

Quark Pharmaceuticals Patents

Quark Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201413533-D0 Combination therapy for treating disorders of the vestibular system Inactive 30-Jul-2014
GB-201413532-D0 Combination therapy for treating hearing disorders Inactive 30-Jul-2014
GB-201413538-D0 Ophthalmic compositions and uses thereof Inactive 30-Jul-2014
GB-201413534-D0 Otic compositions and uses thereof Inactive 30-Jul-2014
AU-2015267160-A1 Methods and compositions for preventing ischemia reperfusion injury in organs Active 29-May-2014 C12N15/1135
To view Quark Pharmaceuticals’s complete patent history, request access »

Quark Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quark Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Quark Pharmaceuticals‘s full profile, request access.

Request a free trial

Quark Pharmaceuticals Investments (1)

Quark Pharmaceuticals’s most recent deal was a Joint Venture with Kunshan RiboQuark Pharmaceutical Technology. The deal was made on 01-Sep-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kunshan RiboQuark Pharmaceutical Technology 01-Sep-2012 Joint Venture Drug Discovery
To view Quark Pharmaceuticals’s complete investments history, request access »

Quark Pharmaceuticals FAQs

  • When was Quark Pharmaceuticals founded?

    Quark Pharmaceuticals was founded in 1994.

  • Where is Quark Pharmaceuticals headquartered?

    Quark Pharmaceuticals is headquartered in Newark, CA.

  • What is the size of Quark Pharmaceuticals?

    Quark Pharmaceuticals has 70 total employees.

  • What industry is Quark Pharmaceuticals in?

    Quark Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Quark Pharmaceuticals a private or public company?

    Quark Pharmaceuticals is a Private company.

  • What is Quark Pharmaceuticals’s current revenue?

    The current revenue for Quark Pharmaceuticals is .

  • How much funding has Quark Pharmaceuticals raised over time?

    Quark Pharmaceuticals has raised $117M.

  • Who are Quark Pharmaceuticals’s investors?

    Astellas Pharma, Astex Pharmaceuticals, Concordia Capital Partners, Daiichi Sankyo, and GoAhead Ventures are 5 of 13 investors who have invested in Quark Pharmaceuticals.

  • Who are Quark Pharmaceuticals’s competitors?

    X-37, Biosplice Therapeutics, Voyager Therapeutics, Numerion Labs, and Exscientia are some of the 63 competitors of Quark Pharmaceuticals.

  • When was Quark Pharmaceuticals acquired?

    Quark Pharmaceuticals was acquired on 01-May-2021.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process